Beacon Investment Advisory Services’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-41,821
Closed -$10.3M 292
2022
Q3
$10.3M Sell
41,821
-1,400
-3% -$378K 0.57% 52
2022
Q2
$10.7M Sell
43,221
-596
-1% -$161K 0.56% 53
2022
Q1
$14.5M Sell
43,817
-2,672
-6% -$823K 0.62% 51
2021
Q4
$16.7M Sell
46,489
-859
-2% -$290K 0.65% 48
2021
Q3
$15.4M Sell
47,348
-2,389
-5% -$809K 0.64% 47
2021
Q2
$15.5M Sell
49,737
-2,933
-6% -$900K 0.63% 50
2021
Q1
$16.8M Sell
52,670
-1,803
-3% -$577K 0.73% 40
2020
Q4
$17.7M Sell
54,473
-2,367
-4% -$655K 0.82% 39
2020
Q3
$15.7M Sell
56,840
-1,825
-3% -$526K 0.82% 39
2020
Q2
$14.2M Sell
58,665
-2,975
-5% -$597K 0.81% 40
2020
Q1
$8.95M Sell
61,640
-10,698
-15% -$1.78M 0.63% 50
2019
Q4
$12.3M Buy
72,338
+69,813
+2,765% +$12.9M 0.66% 49
2019
Q3
$449K Buy
+2,525
New +$546K 0.04% 165

Other funds holding ABMD

Beacon Investment Advisory Services's ABMD Position: Q4 2022 in Review

Beacon Investment Advisory Services sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 41,821 shares — an estimated $10.3M sold.

Beacon Investment Advisory Services first reported a position in ABMD in Q3 2019 and held it in 13 quarters. The position peaked at $17.7M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Beacon Investment Advisory Services reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Beacon Investment Advisory Services sold 41,821 Abiomed Inc shares in Q4 2022, an estimated $10.3M.
  • Beacon Investment Advisory Services first reported a position in Abiomed Inc in Q3 2019 and held it in 13 quarters.
  • Beacon Investment Advisory Services's Abiomed Inc position peaked at $17.7M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Beacon Investment Advisory Services's 13F filing for Q4 2022, filed 13 Jan 2023.